Blog

Categories
  1. Geron's Imetelstat: When is EMA approval coming for the newest MDS treatment?

    When is the new treatment for MDS going to be available to patients outside the USA?

    Read more »
  2. Enhertu as Tumor-Agnostic Therapy: Important Updates for Non-US Cancer Patients

    When will non-US patients have access to Enhertu as a tumor-agnostic treatment.

    Read more »
  3. Crovalimab's approval worldwide: When is the new PNH treatment coming to you?

    When will the new treatment for PNH be available in Europe, the UK, and worldwide?

    Read more »
  4. Anktiva for bladder cancer: How long until it's approved in your country?

    Anktiva, a first-in-class bladder cancer treatment has just been FDA-approved. When will it be available in your country?

    Read more »
  5. Vigafyde: Could the only ready-to-use vigabatrin oral solution be a Sabril alternative?

    How is the new vigabatrin oral solution different from other treatments for infantile spasms? And can it be a Sabril alternative?

    Read more »
  6. Tovorafenib's approval in Europe and around the world: How long will you have to wait?

    When will patients in Europe and the UK have access to the newest treatment for pediatric low-grade glioma?

    Read more »
  7. Tarlatamab's approval in Europe: When is it coming (and how not to wait)?

    When will the newest treatment for extensive-stage small cell lung cancer be available to patients in Europe (and worldwide)?

    Read more »
  8. Donanemab's approval around the world: How long will you have to wait?

    When will the new Alzheimer's medicine get its approval? And how long until it gets to your country?

    Read more »
  9. Nidlegy's approval (FDA, EMA, MHRA and more): How long will you have to wait?

    When is the new treatment for melanoma getting its first global approval? Here's what you need to know.

    Read more »
  10. Dato dxd for breast cancer and lung cancer: When is approval coming?

    When is Dato dxd's EMA approval expected, and what is the fastest way to access this breast and lung cancer treatment?

    Read more »
  11. Linvoseltamab's approval by the EMA (and FDA): How long will you have to wait?

    When will the latest treatment for multiple myeloma get approval - from the EMA, MHRA, and more?

    Read more »
  12. Resminostat's approval by the EMA (and the FDA, MHRA and more): How long will you have to wait?

    When will the newest treatment for cutaneous T-cell lymphoma be available in Europe, the UK, and beyond?

    Read more »
  13. Lazertinib's EMA approval: When will it be available in Europe, the UK, and worldwide?

    When will the new treatment for lung cancer with EGFR and T790M mutations become available in Europe, the UK, and beyond?

    Read more »
  14. Vorasidenib's EMA Approval: When Will It Be Available in Europe, the UK, and Worldwide?

    When will the newest treatment for low-grade glioma become available - in Europe, the UK, and beyond?

    Read more »
  15. Lurbinectedin for Ewing sarcoma and neuroendocrine tumors: Are we there yet?

    Can lurbinectedin be used to treat Ewing sarcoma and neuroendocrine tumors? The latest data and likely approval timelines.

    Read more »
  16. Relyvrio Discontinued: Top Alternatives and How to Continue Your Treatment

    Relyvrio is being pulled off the market. What does it mean for you and your treatment?

    Read more »
  17. Who is a candidate for lecanemab (and how to get the treatment if you qualify)?

    Who qualifies for treatment with lecanemab? And how non-US patients can get the medicine if their doctor prescribes it.

    Read more »
  18. Fruquintinib for gastric cancer: Will it be approved soon?

    Fruquintinib clinical trials in gastric cancer are showing promising results. Will the medicine be approved for this indication soon?

    Read more »
  19. Nirogacestat: What is the new treatment for desmoid tumors?

    All you need to know about Ogsiveo (nirogacestat) and what it could mean for your desmoid tumor treatment.

    Read more »
  20. Lurbinectedin's EMA approval: Is it coming (and when)?

    Will Zepzelca be available to European and UK patients soon? Here's what we know, and your options if you can't wait.

    Read more »
  21. Givinostat's role in polycythemia vera treatment: All you need to know

    Can givinostat be used to treat polycythemia vera? Here's what clinical trial data show.

    Read more »
  22. Givinostat's EMA approval: How long do you have to wait (and how not to)?

    When will the new nonsteroidal treatment for Duchenne be available in the EU and the UK?

    Read more »
  23. Leniolisib's EMA approval: How to prevent delays from delaying your treatment

    When will Joenja be approved (and available) in Europe and the UK? Including how to avoid waiting.

    Read more »
  24. What types of cancer can Tivdak treat? The latest trial data.

    Could Tivdak treat more than cervical cancer? Here's the latest overview of trials focusing on ovarian, head and neck cancers, and more.

    Read more »
  25. Eflornithine for neuroblastoma: EMA approval timelines and how to avoid waiting

    When will European patients have access to the newest FDA-approved neuroblastoma treatment?

    Read more »
  26. Iptacopan's EMA approval is near. When will the medicine be available to you?

    Iptacopan will soon be approved in Europe, but when will it be available to patients?

    Read more »
  27. Retifanlimab for renal cell carcinoma (and other types of cancer)

    Zynyz(retifanlimab) may have a larger role to play in cancer treatment. Find out the latest research in renal cell carcinoma and more.

    Read more »
  28. Everything about eplontersen's EMA approval (and how to get the treatment sooner)

    When will Wainua be available to patients in Europe and the UK? The latest news and all your options in the meantime.

    Read more »
  29. What types of cancer can toripalimab treat?

    Toripalimab is being studied as a treatment of NSCLC, oesophageal cancer, melanoma, and more. What does research tell us, and what does it mean for you?

    Read more »
  30. Can erdafitinib treat breast cancer? The latest data, in simple terms.

    Can Balversa be used to treat breast cancer? What we know from research, and what it means for you.

    Read more »
Page
US 0